Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.

# A.K. Pharma: Your Health, Our Priority

## Sitemaps
[XML Sitemap](https://akpharma.in/sitemap_index.xml): Includes all crawlable and indexable pages.

## Posts
- [Ozempic for Weight Loss in Delhi — What You Need to Know Before Asking Your Doctor](https://akpharma.in/ozempic-for-weight-loss-in-delhi-what-you-need-to-know-before-asking-your-doctor/): Ozempic has become one of the most searched medicine names in India over the past two years. That search volume is not coming from people with diabetes — although Ozempic is a diabetes medicine and that is what it is approved for. It is coming from people who have read about dramatic weight loss results in celebrity interviews, seen before-and-after social media posts, and started wondering whether this is the answer to a problem they have been living with for years.
- [Does Hormone Therapy Cure Prostate Cancer? What Zoladex Actually Does — and Does Not Do](https://akpharma.in/does-hormone-therapy-cure-prostate-cancer-what-zoladex-actually-does-and-does-not-do/): When a urologist or oncologist recommends Zoladex for prostate cancer, the word that tends to echo in the patient's mind — and in the minds of their family — is the word they did not hear. The doctor explained what Zoladex does. They explained how it works, what to expect, what the side effects might be. What they did not say, usually, is the word "cure."
- [Why Some Medicines Are Imported Instead of Manufactured in India](https://akpharma.in/why-some-medicines-are-imported-instead-of-manufactured-in-india/): Walk into any oncology department at a major Indian hospital and you will find medicines from Germany, the United States, Switzerland, Japan, and the United Kingdom sitting alongside domestically manufactured generics. For most patients and their families, this raises a perfectly reasonable question: why is this medicine coming from abroad? Why isn't it made here?
- [India’s First Alzheimer’s Disease-Modifying Therapy Is Now Available — What It Means for Patients and Hospitals](https://akpharma.in/lormalzi-donanemab-alzheimers-india-2026/): For decades, treating Alzheimer's disease in India meant managing symptoms. Medications like rivastigmine and donepezil could slow cognitive decline for a period, but nothing available in the Indian market could actually target the disease process itself — the accumulating amyloid plaques in the brain that are understood to drive the neurodegeneration underlying Alzheimer's.
- [Named Patient Program vs Patient Assistance Program — What Indian Consumers Need to Know](https://akpharma.in/named-patient-program-vs-patient-assistance-program-india/): Two programs. Two very different purposes. And yet, for patients and families navigating serious illness in India, the terms Named Patient Program and Patient Assistance Program come up in the same conversations, recommended by the same doctors, and processed through the same hospital pharmacy counters — which is exactly why so many people end up confused about which one applies to them.
- [The Real Cost of Sourcing Imported Medicines From the Wrong Distributor](https://akpharma.in/the-real-cost-of-sourcing-imported-medicines-from-the-wrong-distributor/): The real cost of sourcing specialty medicines from an unverified or unsuitable Imported medicine distributor in Delhi rarely appears as a single dramatic event. It accumulates — in compromised patient outcomes, in wasted medicine, in regulatory exposure, and in the slow erosion of a procurement team's credibility with the clinical staff who depend on them. Here is what that cost actually looks like, broken down into the categories that matter most.
- [Trodelvy (Sacituzumab Govitecan) in India: A Sourcing Guide for Hospitals Treating Triple-Negative Breast Cancer](https://akpharma.in/trodelvy-sacituzumab-govitecan-sourcing-guide-india/): Trodelvy has become an increasingly requested medicine among Indian oncology centres treating triple-negative breast cancer, a subtype known for its aggressive course and historically limited treatment options. As demand for this antibody-drug conjugate grows, hospital procurement teams and pharmacies are asking more practical questions — less about the science, which is well established in oncology literature, and more about how to source it reliably, verify authenticity, and manage the logistics involved in supplying a complex biologic medicine. This guide addresses those sourcing questions from a distributor's perspective.
- [Denosumab in India 2026: A Distributor’s Guide to Prolia, Xgeva, and Denorange](https://akpharma.in/denosumab-india-2026-prolia-xgeva-denorange/): Although Prolia, Xgeva, and Denorange 60 mg all contain the same denosumab antibody, they are formulated, packaged, and indicated differently according to their respective approved labels. Procurement teams supplying oncology departments should not assume Prolia stock can substitute for Xgeva orders, or vice versa — these products are not interchangeable, and the prescribing physician will have specified one or the other for clinical reasons set out in the approved prescribing information.
- [Zoladex (Goserelin) Injection in India 2026: Complete Guide to Uses, Dosing, and Sourcing for Hospitals and Oncology Centres](https://akpharma.in/zoladex-goserelin-injection-in-india-2026-complete-guide-to-uses-dosing-and-sourcing-for-hospitals-and-oncology-centres/): Goserelin, sold under the brand name Zoladex, has been a cornerstone of hormone therapy for more than three decades, and it remains one of the most consistently prescribed LHRH agonists across Indian oncology and gynaecology practices in 2026. Despite how established the molecule is, hospital pharmacists and procurement teams still raise the same set of practical questions year after year — which strength to stock, how dosing intervals actually work, and how to verify that a batch reaching their facility is genuine. This guide works through all of it in one place.
- [How to Verify That Your Imported Cancer Medicine Is Genuine — A Safety Guide for Hospital Pharmacists in India 2026](https://akpharma.in/how-to-verify-imported-cancer-medicine-genuine-india-2026/): Q. How is A.K. Pharma different from a general pharmaceutical wholesaler? A general pharmaceutical wholesaler deals in high-volume, room-temperature generic medicines from multiple sourcing channels. A.K. Pharma specialises exclusively in imported specialty medicines — with authorised manufacturer supply chains, validated cold chain infrastructure, and complete documentation for every batch. We are a medicine distributor in Delhi built specifically for the specialty and imported medicine segment.
- [Palbociclib, Ribociclib and Abemaciclib in India 2026 — Which CDK4/6 Inhibitor Is Right for Your Patient?](https://akpharma.in/palbociclib-ribociclib-and-abemaciclib-in-india-2026-which-cdk4-6-inhibitor-is-right-for-your-patient/): Breast cancer is now the most commonly diagnosed cancer among Indian women. Within that broad diagnosis, hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer accounts for approximately 60-70% of all cases — and for this large and clinically important group, the treatment landscape has been fundamentally transformed over the past decade by a class of medicines called CDK4/6 inhibitors.
- [Lutetium-177 PSMA Therapy for Prostate Cancer in India — Who Qualifies, How It Works, and Where to Access It in 2026](https://akpharma.in/lutetium-177-psma-therapy-prostate-cancer-india-2026/): A.K. Pharma is a licensed Pharmaceutical distributor in Delhi supplying specialty prostate cancer medicines to hospitals, oncology centres, nuclear medicine facilities, and pharmacies across India.
- [Enhertu and the ADC Revolution — Why Antibody-Drug Conjugates Are the Most Important Development in Cancer Treatment in 2026](https://akpharma.in/enhertu-adc-revolution-cancer-treatment-india-2026/): In December 2019 the FDA approved a new cancer medicine that most oncologists had never heard of. By 2024 it had become the best-selling antibody-drug conjugate in the world — generating USD 3.75 billion in annual sales. By early 2026 it had received Priority Review for yet another new indication and was being described by leading oncologists as the most transformative cancer medicine developed in the past decade.
- [Ozempic vs Mounjaro vs Wegovy in India 2026 — Which GLP-1 Should Your Patient Choose?](https://akpharma.in/ozempic-vs-mounjaro-vs-wegovy-in-india-2026-which-glp-1-should-your-patient-choose/): This article covers the clinical differences, latest India pricing, and trial evidence for the three most discussed GLP-1 medicines in India right now — Ozempic vs Mounjaro India — and Wegovy.
- [How A.K. Pharma Ensures Genuine Medicine Supply Across India](https://akpharma.in/how-a-k-pharma-ensures-genuine-medicine-supply-across-india/): At A.K. Pharma, we understand this responsibility. As a licensed medicine wholesaler in Delhi, we have built our entire business around one principle — every medicine we supply must be 100% genuine.

## Pages
- [Privacy Policy](https://akpharma.in/privacy-policy/): Suggested text: Our website address is: https://akpharma.in.
- [About-2](https://akpharma.in/about-2/): A.K. Pharma has been supplying life-saving specialty medicines from Shastri Nagar, New Delhi since 2000. Over 25 years we have built one of Delhi's most comprehensive specialty medicine portfolios — covering oncology, immunology, endocrinology, rare diseases, and more — supplying hospitals, oncology centres, and pharmacies across India with genuine medicines from authorised sources.
- [Patient Assistance Program (PAP)](https://akpharma.in/patient-assistance-program/): Get access to life-saving specialty and imported medicines through our free Patient Assistance Program. A.K. Pharma works directly with manufacturers to help patients across India access critical medicines at little or no cost.
- [Medicine & Health Blogs](https://akpharma.in/medicine-health-blogs/)
- [A.K. Pharma](https://akpharma.in/): Welcome to A.K. Pharma - Your health, our priority
- [Products](https://akpharma.in/products/): Medicine Category​ Allergy (3) Anti Biotic (16) Anti Coagulant / Anti Platelet (3) Anti Convulsant (1) Anti Epileptic (1) Anti Fungal (7) Anti HIV/ Retroviral (3) Anti Viral (3) Arthritis (3) Asthma (1) Blood (15) Bone (12) Cancer (77) Diabetes (9) Eye (1) Gastrointestinal (1) Heart (11) Hormone (28) immunosuppressant (13) IVF (7) Kidney (6) Liver (1) Lungs (8) Neurology (3) Obesity (2) Pediatric (4) Rare Disease (1) Skin (5) Thyroid (2) Vaccines (3) All Products
- [About Us](https://akpharma.in/about-us/): Based in the bustling city of Delhi, our company has been to supplying high-quality pharmaceutical products that has made a significant impact on people's lives over the span of 20+ years.
- [My account](https://akpharma.in/my-account/): Login Username or email address *Required Password *Required Remember me Log in Lost your password?

## Products
- [Malarone® (Atovaquone + Proguanil)](https://akpharma.in/product/malarone/): Atovaquone 250mg + Proguanil Hydrochloride 100mg Tablets — Antimalarial for Prevention and Treatment of Malaria
- [Capecite® (Capecitabine)](https://akpharma.in/product/capecite/): Capecitabine 500mg Tablets — Oral Antimetabolite Chemotherapy for Breast, Colorectal, and Colon Cancer
- [Bdparib® (Rucaparib)](https://akpharma.in/product/bdparib/): Rucaparib Tablets — PARP Inhibitor for Advanced Ovarian and Prostate Cancer
- [Beyfortus® (Nirsevimab)](https://akpharma.in/product/beyfortus/): Nirsevimab 50mg/0.5mL and 100mg/1mL Injection — Long-Acting Monoclonal Antibody for RSV Prevention in Infants
- [Retevmo® (Selpercatinib)](https://akpharma.in/product/retevmo/): Selpercatinib 40mg and 80mg Capsules — RET Kinase Inhibitor for RET-Altered Lung and Thyroid Cancers
- [Monovisc® (Sodium Hyaluronate)](https://akpharma.in/product/monovisc/): Sodium Hyaluronate 88mg/4mL Single Injection — Viscosupplement for Knee Osteoarthritis Pain Relief
- [Durolane® (Sodium Hyaluronate)](https://akpharma.in/product/durolane/): Sodium Hyaluronate 60mg/3mL Single Injection — Viscosupplement for Knee Osteoarthritis Pain Relief
- [Praluent® (Alirocumab)](https://akpharma.in/product/praluent/): Alirocumab 75mg/mL and 150mg/mL Injection — PCSK9 Inhibitor for Hypercholesterolemia and Cardiovascular Risk Reduction
- [Evenity® (Romosozumab)](https://akpharma.in/product/evenity/): Romosozumab 105mg/1.17mL Injection — Sclerostin Inhibitor for Osteoporosis in Postmenopausal Women at High Fracture Risk
- [Brukinsa® (Zanubrutinib)](https://akpharma.in/product/brukinsa/): Zanubrutinib 80mg Capsules — Second-Generation BTK Inhibitor for CLL, MCL, WM, MZL, and Follicular Lymphoma
- [Lormalzi® (Donanemab)](https://akpharma.in/product/lormalzi/): Donanemab 350mg/20mL Injection — Anti-Amyloid Monoclonal Antibody for Early Symptomatic Alzheimer's Disease
- [Tevimbra® (Tislelizumab)](https://akpharma.in/product/tevimbra/): Tislelizumab 100mg/10mL Injection — PD-1 Checkpoint Inhibitor for Esophageal and Gastric Cancers
- [Scarnet® (Foscarnet Sodium)](https://akpharma.in/product/scarnet/): Foscarnet Sodium 24mg/mL Injection — Antiviral for CMV Retinitis and Acyclovir-Resistant HSV Infections
- [Elahere® (Mirvetuximab Soravtansine)](https://akpharma.in/product/elahere/): Mirvetuximab Soravtansine 100mg Injection — Antibody-Drug Conjugate for Folate Receptor Alpha-Positive Ovarian Cancer
- [Soliris® (Eculizumab)](https://akpharma.in/product/soliris/): Eculizumab 300mg Injection — Complement Inhibitor for PNH, aHUS, and Myasthenia Gravis
- [Tishtha® (Nivolumab)](https://akpharma.in/product/tishtha/): Nivolumab 40mg and 100mg Injection — PD-1 Checkpoint Inhibitor for Multiple Advanced Cancers
- [Pagenax® (Brolucizumab)](https://akpharma.in/product/pagenax/): Brolucizumab Solution for Injection — Anti-VEGF Therapy for Wet Age-Related Macular Degeneration
- [Rahika® (Capmatinib)](https://akpharma.in/product/rahika/): Capmatinib 200mg Tablets — MET Inhibitor for Non-Small Cell Lung Cancer With MET Exon 14 Skipping Mutation
- [Spexib® (Ceritinib)](https://akpharma.in/product/spexib/): Ceritinib 150mg Capsules — ALK Inhibitor for ALK-Positive Metastatic Non-Small Cell Lung Cancer
- [Koselugo® (Selumetinib)](https://akpharma.in/product/koselugo/): Selumetinib 10mg Capsules — MEK Inhibitor for Neurofibromatosis Type 1 Plexiform Neurofibromas
- [Cibinqo® (Abrocitinib)](https://akpharma.in/product/cibinqo/): Abrocitinib 200mg Tablets — JAK1 Inhibitor for Moderate to Severe Atopic Dermatitis
- [Truqap® (Capivasertib)](https://akpharma.in/product/truqap/): Capivasertib 200mg Tablets — AKT Inhibitor for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- [Xolair® (Omalizumab)](https://akpharma.in/product/xolair/): Omalizumab 150mg Injection — Anti-IgE Monoclonal Antibody for Allergic Asthma and Chronic Spontaneous Urticaria
- [EpiPen® (Epinephrine Auto-Injector)](https://akpharma.in/product/epipen/): Epinephrine (Adrenaline) Auto-Injector 0.3mg and 0.15mg — Emergency Treatment for Anaphylaxis and Severe Allergic Reactions
- [Pivikto® (Alpelisib)](https://akpharma.in/product/pivikto/): Alpelisib 150mg, 200mg, 250mg+50mg Film-Coated Tablets — PI3Kα-Selective Inhibitor for HR-Positive HER2-Negative PIK3CA-Mutated Advanced or Metastatic Breast Cancer in Combination With Fulvestrant
- [Nitib® (Ibrutinib)](https://akpharma.in/product/nitib/): Ibrutinib 140mg Capsules — First-in-Class BTK Inhibitor for Chronic Lymphocytic Leukaemia, Mantle Cell Lymphoma, Waldenström's Macroglobulinaemia, Marginal Zone Lymphoma and Chronic Graft-Versus-Host Disease
- [Ramiven® (Abemaciclib)](https://akpharma.in/product/ramiven/): Abemaciclib 50mg, 100mg, 150mg Film Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Breast Cancer in Combination With Endocrine Therapy and as Monotherapy
- [Zoladex® (Goserelin)](https://akpharma.in/product/zoladex-goserelin/): Goserelin 3.6mg, 10.8mg Implant — GnRH Agonist for Hormone-Sensitive Prostate Cancer and Premenopausal Breast Cancer
- [Zelbaoraf® (Vemurafenib)](https://akpharma.in/product/zelbaoraf/): Vemurafenib 240mg Film-Coated Tablets — BRAF V600E Kinase Inhibitor for Unresectable or Metastatic BRAF V600E-Mutated Melanoma and BRAF V600E Mutation-Positive Erdheim-Chester Disease
- [Rafinlar® (Dabrafenib)](https://akpharma.in/product/rafinlar/): Dabrafenib 50mg, 75mg Capsules — BRAF V600 Kinase Inhibitor for BRAF V600-Mutated Metastatic Melanoma, NSCLC, Anaplastic Thyroid Cancer and Other BRAF V600E-Mutated Solid Tumours — Used in Combination With Meqsel (Trametinib)
- [Meqsel® (Trametinib)](https://akpharma.in/product/meqsel/): Trametinib 0.5mg, 2mg Tablets — MEK1/2 Inhibitor for BRAF V600-Mutated Metastatic Melanoma, NSCLC, Anaplastic Thyroid Cancer and Metastatic Solid Tumours
- [Andocur® (Cyproterone Acetate)](https://akpharma.in/product/andocur/): Cyproterone Acetate 50mg, 100mg Tablets — Antiandrogen for Advanced Prostate Cancer, Hot Flushes From GnRH Agonist Therapy and Severe Hypersexuality
- [Tibsovo® (Ivosidenib)](https://akpharma.in/product/tibsovo/): Ivosidenib 250mg Tablets — IDH1 Inhibitor for IDH1-Mutated Acute Myeloid Leukaemia, Myelodysplastic Syndromes and Previously Treated IDH1-Mutated Cholangiocarcinoma
- [Balversa® (Erdafitinib)](https://akpharma.in/product/balversa/): Erdafitinib 3mg, 4mg, 5mg Tablets — Pan-FGFR Tyrosine Kinase Inhibitor for Locally Advanced or Metastatic Urothelial Carcinoma With FGFR2 or FGFR3 Alterations
- [Trodelvy® (Sacituzumab Govitecan)](https://akpharma.in/product/trodelvy/): Sacituzumab Govitecan 180mg Injection — TROP-2 Targeted Antibody-Drug Conjugate for Triple-Negative Breast Cancer and HR-Positive HER2-Negative Breast Cancer
- [Blincyto® (Blinatumomab)](https://akpharma.in/product/blincyto/): Blinatumomab 35mcg Injection — First-in-Class BiTE Antibody for Philadelphia Chromosome-Negative and Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukaemia
- [Enhertu® (Trastuzumab Deruxtecan)](https://akpharma.in/product/enhertu-trastuzumab-deruxtecan/): Trastuzumab Deruxtecan 100mg Injection — HER2-Targeted Antibody-Drug Conjugate for HER2-Positive and HER2-Low Breast Cancer, Gastric Cancer and HER2-Mutant NSCLC
- [Imjudo® (Tremelimumab)](https://akpharma.in/product/imjudo/): Tremelimumab 300mg Injection — Anti-CTLA-4 Monoclonal Antibody Used in Combination With Imfinzi (Durvalumab) for Unresectable Hepatocellular Carcinoma and Extensive-Stage Small Cell Lung Cancer
- [Palbace® (Palbociclib)](https://akpharma.in/product/palbace/): Palbociclib 75mg, 100mg, 125mg Capsules — First-in-Class CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer in Combination With Endocrine Therapy
- [Kryxana® (Ribociclib)](https://akpharma.in/product/kryxana/): Ribociclib 200mg Film-Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer With Proven Overall Survival Benefit Across Pre/Perimenopausal and Postmenopausal Women
- [Aromasin® (Exemestane)](https://akpharma.in/product/aromasin/): Exemestane 25mg Film-Coated Tablets — Steroidal Aromatase Inactivator for Hormone Receptor-Positive Breast Cancer in Postmenopausal Women
- [Glenza® (Enzalutamide)](https://akpharma.in/product/glenza/): Enzalutamide 40mg, 160mg Capsules — Androgen Receptor Signalling Inhibitor for Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer and Non-Metastatic Castration-Resistant Prostate Cancer
- [Scapho® (Secukinumab)](https://akpharma.in/product/scapho/): Secukinumab 150mg, 300mg Injection — Anti-IL-17A Monoclonal Antibody for Moderate-Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
- [Copellor® (Ixekizumab)](https://akpharma.in/product/copellor/): Ixekizumab 80mg/mL Injection — Anti-IL-17A Monoclonal Antibody for Moderate-Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
- [Ninlib® (Nilotinib)](https://akpharma.in/product/ninlib/): Nilotinib 150mg, 200mg Capsules — Second Generation BCR-ABL Tyrosine Kinase Inhibitor for Philadelphia Chromosome-Positive Chronic Myeloid Leukaemia
- [Abirapro® (Abiraterone Acetate)](https://akpharma.in/product/abirapro-abiraterone-acetate/): Abiraterone Acetate 250mg, 500mg Tablets — CYP17A1 Inhibitor for Metastatic Castration-Resistant and High-Risk Metastatic Hormone-Sensitive Prostate Cancer
- [Firmagon](https://akpharma.in/product/firmagon/): Degarelix 80mg, 120mg Injection — GnRH Receptor Antagonist for Advanced Hormone-Sensitive Prostate Cancer
- [Menopur® (Menotrophin)](https://akpharma.in/product/menopur/): Menotrophin 75IU, 600IU, 1200IU Injection — Highly Purified FSH + LH for Controlled Ovarian Stimulation in IVF, ICSI and IUI
- [Sybrava® (Inclisiran)](https://akpharma.in/product/sybrava/): Inclisiran 284mg Injection — siRNA PCSK9 Inhibitor for Hypercholesterolaemia and Cardiovascular Risk Reduction
- [Repatha® (Evolocumab)](https://akpharma.in/product/repatha/): Evolocumab 140mg Injection — PCSK9 Inhibitor for Hypercholesterolaemia and Cardiovascular Risk Reduction

## Categories
- [Blog](https://akpharma.in/category/blog/)
- [Breast Cancer](https://akpharma.in/category/breast-cancer/)
- [Cancer](https://akpharma.in/category/cancer/)
- [Diabetes](https://akpharma.in/category/diabetes/)
- [Educational/informational](https://akpharma.in/category/educational-informational/)
- [Medicine Safety](https://akpharma.in/category/medicine-safety/)
- [Medicine Wholsaler](https://akpharma.in/category/medicine-wholsaler/)
- [Obesity](https://akpharma.in/category/obesity/)
- [Patient Access](https://akpharma.in/category/patient-access/)
- [Prostate Cancer](https://akpharma.in/category/prostate-cancer/)

## Tags

## Product tags

## Product categories
- [Allergy](https://akpharma.in/product-category/allergy/)
- [Anti Biotic](https://akpharma.in/product-category/anti-biotic/)
- [Anti Coagulant / Anti Platelet](https://akpharma.in/product-category/anti-coagulant/)
- [Anti HIV/ Retroviral](https://akpharma.in/product-category/hiv-retroviral/)
- [Anti Viral](https://akpharma.in/product-category/anti-viral/)
- [Arthritis](https://akpharma.in/product-category/arthritis/)
- [Asthma](https://akpharma.in/product-category/lungs/asthma/)
- [Blood](https://akpharma.in/product-category/blood/)
- [Bone](https://akpharma.in/product-category/bone/)
- [Cancer](https://akpharma.in/product-category/cancer/)
- [Diabetes](https://akpharma.in/product-category/diabetes/)
- [Eye](https://akpharma.in/product-category/eye/)
- [Gastrointestinal](https://akpharma.in/product-category/gastro/)
- [Heart](https://akpharma.in/product-category/heart/)
- [Hormone](https://akpharma.in/product-category/hormones/)
- [immunosuppressant](https://akpharma.in/product-category/immunosuppressant/)
- [IVF](https://akpharma.in/product-category/ivf/)
- [Kidney](https://akpharma.in/product-category/kidney/)
- [Liver](https://akpharma.in/product-category/liver/)
- [Lungs](https://akpharma.in/product-category/lungs/)
- [Neurology](https://akpharma.in/product-category/neurology/)
- [Obesity](https://akpharma.in/product-category/obesity/)
- [Pediatric](https://akpharma.in/product-category/pediatric/)
- [Rare Disease](https://akpharma.in/product-category/rare-disease/)
- [Skin](https://akpharma.in/product-category/skin/)
- [Thyroid](https://akpharma.in/product-category/thyroid/)
- [Vaccines](https://akpharma.in/product-category/vaccines/)
- [Anti Convulsant](https://akpharma.in/product-category/anti-convulsant/)
- [Anti Epileptic](https://akpharma.in/product-category/anti-epileptic/)
- [Anti Fungal](https://akpharma.in/product-category/anti-fungal/)